FDA Update – July/August 2012
News about pertuzumab injection (Perjeta); ondansetron (Zofran); carfilzomib (Kyprolis); Therascreen KRAS RGQ PCR Kit; Prostate Health Index (phi); and Prepopik
News about pertuzumab injection (Perjeta); ondansetron (Zofran); carfilzomib (Kyprolis); Therascreen KRAS RGQ PCR Kit; Prostate Health Index (phi); and Prepopik
HIV-positive women with normal Pap results and no oncogenic HPV do not appear to be at greater risk of cervical CA than HIV-negative women.
CT colonography can accurately detect adenomas 10 mm or larger in patients who did not undergo laxative-induced bowel cleansing before the procedure.
The antipsychotic agent thioridazine (Mellaril) selectively inhibits cancer stem cells without damaging normal blood cells, researchers found.
A high-speed DNA-decoding technology identified minimal residual disease in nearly twice as many persons with leukemia as did flow cytometry.
USPSTF has issued a final recommendation against PSA-based screening for prostate cancer for all men, regardless of age.
A specific genomic abnormality found in either benign or malignant prostate tissues is predictive of the clinical outcome of prostate cancer.
Researchers at Seidman Cancer Center in Cleveland are recruiting patients for a study of a new, noninvasive technology for colon cancer screening.
Adenomas and high-risk lesions were frequently detected on repeat colonoscopy, suggesting the lesions were missed on initial colonoscopy.
CT colonography accurately detects cancer and precancerous polyps in persons aged 65 years and older.